Načítá se...
P01.154 Volumetric response to TTFields in newly diagnosed GBM
BACKGROUND: Optune TTField treatment is an established, non-invasive therapy for patients with newly diagnosed or recurrent glioblastoma (GBM). Treatment efficacy was evaluated demonstrating significant improvement of both, overall and progression free survival. For analysis, the MacDonald criteria...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144615/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.196 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|